Univariable analysis | Multivariable analysis | |||||
---|---|---|---|---|---|---|
HR | 95% CI | P-Value | HR | 95% CI | P-Value | |
Sex | ||||||
Male | 1 | reference | 1 | reference | ||
Female | 0.843 | 0.578–1.228 | 0.374 | 0.798 | 0.544–1.171 | 0.798 |
Age (years) | ||||||
≤ 60 | 1 | reference | 1 | reference | ||
> 60 | 0.872 | 0.581–1.310 | 0.510 | 0.909 | 0.590–1.399 | 0.664 |
Tumor length (continuous) | 1.008 | 0.999–1.017 | 0.099 | |||
NELNs | ||||||
≤ 15 | 1 | reference | 1 | reference | ||
> 15 | 0.661 | 0.442–0.989 | 0.044 | 0.650 | 0.431–0.979 | 0.039 |
Tumor differentiation | ||||||
Well-moderate | 1 | reference | 1 | reference | ||
Poor | 1.192 | 0.806–1.763 | 0.378 | 1.128 | 0.756–1.684 | 0.554 |
pT stage | ||||||
T1 | 1 | reference | 1 | reference | ||
T2-T3 | 1.792 | 1.216–2.642 | 0.003 | 1.861 | 1.256–2.756 | 0.002 |
Tumor Location | ||||||
Upper-middle | 1 | reference | ||||
Lower | 0.973 | 0.662–1.429 | 0.888 | |||
Race | ||||||
White patients | 1 | reference | 1 | reference | ||
Other patients | 1.035 | 0.694–1.544 | 0.865 | 0.984 | 0.647–1.497 | 0.984 |